Your browser doesn't support javascript.
loading
Metrological properties of neuropsychological tests for measuring cognitive change in individuals with prodromal Alzheimer's disease.
Zhang, Xinnan; Wu, Yan; He, Yao; Ge, Xiaoyan; Cui, Jing; Han, Hongjuan; Luo, Yanhong; Liu, Long; Wang, Zhixin; Yu, Hongmei.
Afiliação
  • Zhang X; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Wu Y; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • He Y; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Ge X; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Cui J; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Han H; bDepartment of Mathematics, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
  • Luo Y; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Liu L; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Wang Z; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
  • Yu H; Department of Health Statistics, School of Public Health, Shanxi Medical University, Taiyuan, China.
Aging Ment Health ; 26(10): 1988-1996, 2022 10.
Article em En | MEDLINE | ID: mdl-34409904
ABSTRACT

OBJECTIVES:

In Alzheimer's Disease (AD) research, choosing appropriate method for measuring change in cognitive function over time can be challenging. The aim for this study was to examine the sensitivity of four neuropsychological tests used to measure cognition during the transition from mild cognitive impairment (MCI) to AD, and the impacts of associated covariates.

METHODS:

We enrolled 223 patients with MCI who progressed to AD and had completed multiple follow-up assessments in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We constructed nonlinear mixed model for multivariate longitudinal data assuming that multiple neuropsychological tests would exhibit nonlinear transformation of a common factor in the latent cognitive process underlying the progression from MCI to AD.

RESULTS:

The Clinical Dementia Rating-Sum of the Boxes (CDR-SB) and Alzheimer's Disease Assessment Scale (11 items; ADAS-11) were more sensitive to cognitive changes in individuals with higher cognitive function, the Functional Activities Questionnaire (FAQ) was more sensitive to cognitive changes in individuals with middle cognitive function, and the Mini-Mental State Examination (MMSE) was more sensitive to cognitive changes in individuals with lower cognitive function. Gender (p = 0.0139) and educational level (p = 0.0094) had varying effects on different tests, such that men performed better on the FAQ and CDR-SB, and individuals with higher educational level tended to perform better on the FAQ and MMSE.

CONCLUSIONS:

When choosing appropriate neuropsychological tests in cognitive measurements, the cognitive functional level of the patient as well as the impacts of covariates should be considered.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Limite: Humans / Male Idioma: En Ano de publicação: 2022

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva Limite: Humans / Male Idioma: En Ano de publicação: 2022